Nektar Therapeutics

NASDAQ: NKTR · Real-Time Price · USD
27.24
0.55 (2.06%)
At close: Aug 15, 2025, 3:59 PM
26.80
-1.62%
After-hours: Aug 15, 2025, 07:25 PM EDT

Nektar Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-41.59M -50.88M 7.26M -37.06M -52.36M -36.8M -42.08M -45.84M -51.12M -137.02M -59.69M -59.05M -159.07M -90.39M -145.65M -129.71M -125.52M -122.97M
Depreciation & Amortization
-655K 426K 332K -6.72M 1.46M 1.61M 1.65M 1.7M 2.17M 2.3M 3.18M 2.68M 3.44M 3.73M 3.44M 3.62M 3.55M 3.54M
Stock-Based Compensation
3.49M 3.9M 4.8M 5.39M 5.42M 6M 7.25M 8.15M 7.97M 10.02M 12.74M 12.52M 11.1M 20.96M 22.41M 24.66M 23.71M 23.9M
Other Working Capital
-57K -6.56M -14.31M -5.7M 10.45M -2.08M -13.25M -5.4M -9.19M 5.45M -20.76M -17.14M 3.36M 18.82M -40.93M -6.22M 15.12M 8.76M
Other Non-Cash Items
-3.4M -2.35M -47.08M -1.33M -3.08M -12.03M -10.86M -1.63M -1.45M 77.07M -8.57M -11.26M 47.71M -37.23M 19.72M 677K -2.08M -909K
Deferred Income Tax
n/a n/a 12K -31K 57K -38K 1.71M -15K -27K -1.81M 2.71M n/a n/a n/a 383K 3.33M 2.71M 1.6M
Change in Working Capital
-3.58M -146K -11.52M -4.18M 10.8M -6.62M -4.73M -4.49M -9.06M -2.47M -8.07M -27.77M 21.82M 14.51M -51.83M -3.71M 14.72M 17.75M
Operating Cash Flow
-45.74M -49.05M -46.19M -43.93M -37.7M -47.89M -47.05M -42.12M -51.52M -51.91M -57.7M -82.89M -74.99M -88.42M -151.54M -101.14M -82.9M -77.08M
Capital Expenditures
-37K -2K -459K -666K -186K -157K -237K -33K -162K -433K -512K -181K -780K -4.2M -5.9M -2.94M -3.28M -2.88M
Cash Acquisitions
n/a n/a 65.39M n/a n/a n/a 65.12M 1.25M -25.33M n/a 13.2M -111.58M -84.93M n/a n/a n/a n/a n/a
Purchase of Investments
-18.92M -24.93M -69.83M -18.38M -68.44M -105.06M -138.88M -123.1M -142.71M -107.01M -172.47M -48.42M -153.52M -93.49M -144.64M -288.16M -232.57M -295.31M
Sales Maturities Of Investments
68.57M 69.32M 65.11M 65.16M 85.61M 124.47M 156.5M 178.3M 168.04M 148.04M 199.81M 160M 238.45M 227.97M 270.73M 290.27M 308.81M 308.65M
Other Investing Acitivies
n/a -697K n/a n/a n/a n/a -65.12M n/a 25.33M n/a 40.53M 111.58M 84.93M 134.48M 126.09M 2.11M 76.23M 13.33M
Investing Cash Flow
49.62M 43.69M 60.21M 46.12M 16.98M 19.26M 17.38M 56.41M 25.17M 40.6M 40.01M 111.39M 84.15M 130.28M 120.2M -830K 72.95M 10.46M
Debt Repayment
n/a n/a n/a n/a n/a 15M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a -3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -2.92M n/a n/a 30M n/a -64.92M 18K n/a 103K n/a 467K 938K 2.55M 3.66M 12.17M 17.86M
Financial Cash Flow
211K 7K 83K 13K 19K 42M 12K -64.92M 18K n/a 103K n/a 467K 938K 2.55M 3.66M 12.17M 17.86M
Net Cash Flow
4.09M -5.36M 14.14M 2.14M -20.82M 14.58M -29.57M -50.73M -26.23M -11.27M -17.53M 28.21M 9.55M 42.77M -28.8M -98.33M 2.18M -48.79M
Free Cash Flow
-45.77M -49.05M -46.65M -44.6M -37.89M -48.05M -47.28M -42.15M -51.69M -52.35M -58.22M -83.07M -75.77M -92.63M -157.43M -104.07M -86.18M -79.96M